Article

Benefit finding, affective reactions to diabetes stress, and diabetes management among early adolescents.

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9044, USA.
Health Psychology (Impact Factor: 3.95). 03/2011; 30(2):212-9. DOI: 10.1037/a0022378
Source: PubMed

ABSTRACT To examine whether benefit finding was associated with better adjustment among adolescents with diabetes by buffering negative affective reactions to diabetes stress and by promoting positive affective reactions.
Early adolescents aged 10-14 with Type 1 diabetes (n = 252) described recent diabetes stressors, affective reactions, and perceived coping effectiveness. They also completed measures of benefit finding, depressive symptoms, and adherence. Metabolic control (i.e., HbA1c) was obtained from medical records.
The main outcome measures were perceived coping effectiveness, depressive symptoms, adherence, and HbA1c.
Benefit finding was associated with lower depressive symptoms, higher perceived coping effectiveness and better adherence, and with higher positive as well as negative affective reactions to diabetes stress. Benefit finding interacted with negative affective reactions to predict depressive symptoms and HbA1c. Negative affective reactions to stress were associated with poorer adjustment among those with low benefit finding, but were unrelated or more weakly related to poor adjustment among those with high benefit finding. Positive affective reactions did not mediate associations between benefit finding and any outcome.
Consistent with a stress-buffering process, benefit finding may be a resource that buffers the disruptive aspects of negative affective reactions to stress for adolescents' diabetes management.

0 Bookmarks
 · 
98 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Depression compromises diabetes treatment in juveniles, and this study aimed to identify influential targets most likely to improve adherence to treatment and glycemic control. Prospective observational studies investigating associations between depression and treatment adherence in juveniles with type 1 diabetes were extracted from MEDLINE, EMBASE, CINAHL, PsycINFO and Cochrane Central. Nineteen studies comprising 2,935 juveniles met our criteria. Median effect sizes between depression and treatment adherence were 0.22 (interquartile range (IQR), 0.16-0.35) by patient and 0.13 (IQR, 0.12-0.24) caregiver report. Corresponding values for depression/glycemic control were 0.16 (IQR, 0.09-0.23) and 0.08 (IQR, 0.04-0.14), respectively. Effect sizes varied with study design, publication year and assessment tools: CES-D yielded a higher effect size than other assessment tools for depression, where associations for depression and either adherence or glycemic control was investigated. Several behaviours influenced adherence and glycemic control. Conclusion: This study showed moderate associations between depression and poor treatment adherence. Targeting behaviour and social environments, however, may ultimately provide more cost-effective health gains than targeting depressive symptoms.
    European Journal of Pediatrics 08/2013; · 1.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of diabetes mellitus is on the rise around the world. Middle Eastern countries will be facing a vast increase in the number of diabetes mellitus cases by 2030. Diagnosis of a chronic disease such as diabetes mellitus can be a shocking and life-altering event. Conversely, a diagnosis of a chronic illness can also offer the patient opportunities to change unhealthy behaviors such as poor diet, smoking, and lack of exercise, making them healthier than before their diagnosis. This is referred to as "benefit finding". This study reveals the many benefit findings of Iranian patients who have been diagnosed with diabetes mellitus and illustrates how benefit finding can be an integral part of long-term patient care.
    ISRN nursing. 01/2014; 2014:371296.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The diagnosis and treatment of any chronic illness are a major source of stress for most individuals. Although many individuals living with chronic illness report experiencing growth that arises from this experience, studies have revealed mixed results regarding the association between reported growth and other aspects of psychological well-being. This pilot study examines the complementary and buffering influences of self-growth on self-loss in perceptions of physical and mental health among individuals living with HIV (N = 60). The sample was comprised of a racially/ethnically diverse sample of men and women ranging in age from 27 to 62. Measures included impact of illness on Self-Concept Scale, the Medical Outcomes Study HIV Health Survey, the HIV Symptom Index, and the Center for Epidemiological Studies Depression Scale. Regression analyses were conducted to examine the impact of self-growth and self-loss on self-reported bothersome symptoms and depression, controlling for demographic covariates and physical health. Self-loss accounted for a significant proportion of variance in both bothersome symptom reports and depression, after controlling for physical health. In multivariate analysis, self-growth appeared to buffer the negative impact of self-loss on bothersome symptoms, but not on depression. These data suggest that self-loss is a critical construct in understanding adaptation to chronic illness, and that identity processes may influence symptom perception and mental health outcomes above and beyond the impact of traditional measures of health status.
    Psychology Health and Medicine 11/2013; · 1.38 Impact Factor

Full-text

Download
1 Download
Available from